BIIB
Price
$215.63
Change
-$0.71 (-0.33%)
Updated
Mar 28, 6:59 PM EST
26 days until earnings call
GILD
Price
$73.25
Change
+$0.24 (+0.33%)
Updated
Mar 28, 6:59 PM EST
27 days until earnings call
Ad is loading...

Compare predictions BIIB vs GILD

Header iconBIIB vs GILD Comparison
Open Charts BIIB vs GILDBanner chart's image
Biogen
Price$215.63
Change-$0.71 (-0.33%)
Volume$910.16K
CapitalizationN/A
Gilead Sciences
Price$73.25
Change+$0.24 (+0.33%)
Volume$5.01M
CapitalizationN/A
View a ticker or compare two or three
BIIB vs GILD Comparison Chart

Loading...

BIIBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
GILDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BIIB vs. GILD commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a Hold and GILD is a StrongBuy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (BIIB: $215.63 vs. GILD: $73.24)
Brand notoriety: BIIB and GILD are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BIIB: 147% vs. GILD: 87%
Market capitalization -- BIIB: $31.34B vs. GILD: $91.24B
BIIB [@Pharmaceuticals: Major] is valued at $31.34B. GILD’s [@Pharmaceuticals: Major] market capitalization is $91.24B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIIB’s FA Score shows that 1 FA rating(s) are green whileGILD’s FA Score has 2 green FA rating(s).

  • BIIB’s FA Score: 1 green, 4 red.
  • GILD’s FA Score: 2 green, 3 red.
According to our system of comparison, GILD is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIIB’s TA Score shows that 4 TA indicator(s) are bullish while GILD’s TA Score has 4 bullish TA indicator(s).

  • BIIB’s TA Score: 4 bullish, 4 bearish.
  • GILD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GILD is a better buy in the short-term than BIIB.

Price Growth

BIIB (@Pharmaceuticals: Major) experienced а -2.32% price change this week, while GILD (@Pharmaceuticals: Major) price change was +0.21% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.67%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was -2.01%.

Reported Earning Dates

BIIB is expected to report earnings on Apr 24, 2024.

GILD is expected to report earnings on Apr 25, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (+0.67% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for BIIB with price predictions.
OPEN
A.I.dvisor published
a Summary for GILD with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
GILD($91.2B) has a higher market cap than BIIB($31.3B). BIIB has higher P/E ratio than GILD: BIIB (27.06) vs GILD (16.28). GILD YTD gains are higher at: -8.665 vs. BIIB (-16.671). GILD has higher annual earnings (EBITDA): 10.5B vs. BIIB (2.04B). GILD has more cash in the bank: 7.26B vs. BIIB (1.05B). BIIB has less debt than GILD: BIIB (7.34B) vs GILD (25B). GILD has higher revenues than BIIB: GILD (27.1B) vs BIIB (9.84B).
BIIBGILDBIIB / GILD
Capitalization31.3B91.2B34%
EBITDA2.04B10.5B19%
Gain YTD-16.671-8.665192%
P/E Ratio27.0616.28166%
Revenue9.84B27.1B36%
Total Cash1.05B7.26B14%
Total Debt7.34B25B29%
FUNDAMENTALS RATINGS
BIIB vs GILD: Fundamental Ratings
BIIB
GILD
OUTLOOK RATING
1..100
5562
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
10029
SMR RATING
1..100
7740
PRICE GROWTH RATING
1..100
6359
P/E GROWTH RATING
1..100
1384
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GILD's Valuation (3) in the Biotechnology industry is significantly better than the same rating for BIIB (95). This means that GILD’s stock grew significantly faster than BIIB’s over the last 12 months.

GILD's Profit vs Risk Rating (29) in the Biotechnology industry is significantly better than the same rating for BIIB (100). This means that GILD’s stock grew significantly faster than BIIB’s over the last 12 months.

GILD's SMR Rating (40) in the Biotechnology industry is somewhat better than the same rating for BIIB (77). This means that GILD’s stock grew somewhat faster than BIIB’s over the last 12 months.

GILD's Price Growth Rating (59) in the Biotechnology industry is in the same range as BIIB (63). This means that GILD’s stock grew similarly to BIIB’s over the last 12 months.

BIIB's P/E Growth Rating (13) in the Biotechnology industry is significantly better than the same rating for GILD (84). This means that BIIB’s stock grew significantly faster than GILD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIIBGILD
RSI
ODDS (%)
Bullish Trend 1 day ago
61%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
53%
Momentum
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
50%
MACD
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
51%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
54%
Advances
ODDS (%)
Bullish Trend 18 days ago
55%
Bullish Trend 1 day ago
53%
Declines
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
56%
Aroon
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
52%
View a ticker or compare two or three
Ad is loading...
BIIBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
GILDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTR10.620.22
+2.12%
Mesa Royalty Trust
DH8.070.16
+2.02%
Definitive Healthcare Corp
BLFY9.310.04
+0.43%
Blue Foundry Bancorp
PGNY38.150.16
+0.42%
Progyny
GLW32.96-0.06
-0.18%
Corning

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with BMY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then BMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
-0.32%
BMY - BIIB
39%
Loosely correlated
+1.84%
GILD - BIIB
37%
Loosely correlated
+0.32%
AMGN - BIIB
35%
Loosely correlated
-0.72%
MRK - BIIB
29%
Poorly correlated
+0.15%
NVS - BIIB
29%
Poorly correlated
+0.89%
More

GILD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with AMGN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
+0.32%
AMGN - GILD
44%
Loosely correlated
-0.72%
BIIB - GILD
35%
Loosely correlated
-0.32%
BMY - GILD
34%
Loosely correlated
+1.84%
MRK - GILD
30%
Poorly correlated
+0.15%
JNJ - GILD
29%
Poorly correlated
+0.15%
More